Investor FAQs
Please call Investor Relations (763-505-2692) for
- General investor questions about Medtronic plc
- Requests for Paper Copies of Financial Materials: Annual Reports, SEC Filings etc. (Electronic copies are available on under the SEC filings menu on the Medtronic Investor Relations page or through www.sec.gov)
- If you are a Stock Analyst, Institutional Investor, Portfolio Managers, Stock Brokers or Individual Investor with a question about Medtronic’s operations.
Please call Shareholder Services (763-505-2510) for
- Inquires about Medtronic's transfer agent - EQ Shareowner Services (Contact information about EQ is listed below)
- Inquires about shares in a company that was acquired by Medtronic or questions about acquisition share redemption.
- Questions on Proxy Voting Rights.
Investor Relations can be contacted several ways. To contact us via U.S. mail:
Medtronic plc
Investor Relations
710 Medtronic Parkway N.E., LC-480
Minneapolis, MN 55432-5604
The Investor Relations e-mail address is:
Investor.Relations@Medtronic.com
To phone Investor Relations, call (763) 505-2692.
To contact us via U.S. mail:
Medtronic, Inc.
Shareholder Services
710 Medtronic Parkway N.E., LC-300
Minneapolis, MN 55432-5604
The Shareholder Services e-mail address is:
Shareholder.Services@Medtronic.com
To phone Shareholder Services, call (763) 505-2510.
All of these questions require action by Medtronic's transfer agent, EQ Shareowner Services. Medtronic has a direct dedicated phone number for Medtronic shareholders. To reach EQ within the continental United States dial: (888) 648-8154. If you are calling from outside the U.S. dial: (651) 450-4064.
Medtronic shares are traded on the New York Stock Exchange (NYSE) under the ticker MDT and may be purchased though any licensed broker dealer. Medtronic also has a direct stock purchase plan, called Shareowner Service Plus Plan and a Dividend Reinvestment Plan. These plans are administered by EQ Shareowner Services. Direct purchase accounts set up though EQ can be viewed on-line via the EQ webpage link:
https://www.shareowneronline.com/PlanMaterial.aspx?Type=Dpp&Plan=Mdt1. http://www.wellsfargo.com/com/shareowner_services. -->
EQ Shareowner Services
Shareowner Relations Department
P.O. Box 64856
St. Paul, MN 55164-0856
U.S. Residents: (888) 648-8154
Outside the U.S.: (651) 450-4064
Via e-mail: stocktransfer@wellsfargo.com
You can download or request paper copies of the Medtronic's annual report or SEC filings. To download the SEC documents click here: Medtronic Inc. SEC Filings.
To request paper copies please contact Medtronic Investor Relations Department.
Medtronic stock split history:
Since going public in 1960, Medtronic has distributed the following two-for-one stock splits:
RECORD DATE | DATE PAID |
10-September-1999 | 24-September-1999 |
29-August-1997 | 12-September-1997 |
14-September-1995 | 29-September-1995 |
15-September-1994 | 30-September-1994 |
09-August-1991 | 30-August-1991 |
10-August-1989 | 31-August-1989 |
10-July-1980 | 31-July-1980 |
09-September-1972 | 29-September-1972 |
03-January-1969 | 17-January-1969 |
04-August-1967 | 17-August-1967 |
Information regarding historical stock prices can be found on the Historical Price Lookup page. Click Here.
Share price history prior to 1977 can be difficult to obtain as it does not apprear on electronic data bases. We have provided reference data. Under the Stock Information tab, please see the MDT share price history 1960-1977 spread sheet for more detail.
Please visit the Dividend History for detail regarding dividends. Click Here
Medtronic Inc’s CUSIP was: 585055106
Medtronic plc’s CUSIP is: G5960L 103
*Cusip: Committee on Uniform Security Identification Procedures
Medtronic Inc’s ISIN was: US5850551061
Medtronic plc’s ISIN is: IE00BTN1Y115
*ISIN: International Securities Identification Number
Medtronic plc’s SEDOL is: BTN1Y11
Medtronic ends our fiscal calendar year the last Friday in April.
Pricewaterhouse Coopers
A listing of the Board of Directors can be found in the Corporate Governance section of this web site. Board of Directors
Please submit your question using our Contact Us form